Effectiveness Ankle-7 Orthosis VS HAFO Orthosis on Gait in Diplegic CPChildren

November 2, 2017 updated by: NEVIANI RITA, Arcispedale Santa Maria Nuova-IRCCS

Effectiveness of Ankle-7 Orthosis vs HAFO Orthosis on Gait Performance in Diplegic Cerebral Palsied Children

Ankle foot orthoses (AFO) are frequently used to improve locomotor skills of cerebral palsied children (CP) although the level of scientific evidence to support their use is still moderate. Carbon Ankle Seven spring (A7 - Otto Bock, Germany) is specifically designed to store energy when loaded and release it at toe-off in order to improve gait performance with respect to non-energy-storing AFOs. The aim of this work is to verify the superiority of the ankle-7 orthosis compared to the more widespread AFO, to improve the functionality and walking function of children with spastic diplegia and PCI.

Study Overview

Detailed Description

The project is divided into the following phases:

T0 - at the beginning of the study children included will be subject to the following procedures and assessments:

  1. demographic and anthropometric data collection;
  2. randomization by concealed allocation to one of the following two groups:

    • AFO - Ankle_7 group
    • Ankle-7 - AFO group Both, AFO and ankle-7, will be tailored to the patient

    The two groups are distinguished by the order of the assignment of the two orthoses, respectively defined as the first assignment orthosis (O_1) and second assignment orthosis (O_2). The first group will use the orthoses AFO as a first assignment and then the orthoses Ankle_7, while the second group will use the two orthoses according to the reverse order. The two will be used with the same orthotic footwear, with the exception of the cases where it will be necessary to change it due to accretion.

  3. collection of the measures necessary for making the two orthotic devices at OttoBock of Reggio Emilia
  4. training in the use of the orthoses according to a standardized protocol;
  5. try on the patient's in-process first assignment orthoses (O_1) and subsequent delivery of them (see Annex A);

Subsequently, the patient will use O_1 for a period of 4-6 weeks.

T1 - patients will receive the following procedures and assessments:

  1. try on the patient's in-process second assignment orthoses (O_2)
  2. instrumental gait analysis and video recording of the walking while using O_1 (covered by elastic gaiters);
  3. withdrawal of O_1
  4. delivery of O_2 to the patient

Subsequently, the patient will use O_2 for a period of 4-6 weeks.

T2 - patients will undergo the following procedures and evaluations:

  1. instrumental gait analysis and video recording of the walking while using O_2 (covered by elastic gaiters);
  2. return of O_1 to the patient;
  3. Delivery of the diaries and directions for completing and mailing back them at the end of the follow-up period;

T3 - three months follow-up to detect the preference of use of AFO or Ankle-7 (by the child/parent)

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • - Clinical indication to the use of orthoses to improve the walking function confirmed by instrumental parameters obtained from analysis of the path (dynamic electromyography, optoelectronic stereophotogrammetry analysis);
  • Patients who already have AFO orthoses (or ankle-7) that need to be renewed;
  • Patients with new clinical indication to the use of orthoses but not yet in possession of the same;
  • Informed consent from parents / guardians of the child

Exclusion Criteria:

  • Cognitive disabilities that may affect the child's participation in the activities related to this study, in the opinion of the investigators;
  • Lower limbs sensory disability that may affect any beneficial effects of the use of the orthoses, in the opinion of the investigators;
  • Other diseases associated or not associated with PCI that, according to investigators, could affect the child's participation in the activities related to this study (eg: drug-resistant epilepsy);
  • Administration of antispasmodic drugs in the last 6 months;
  • Functional surgery of the lower limbs in the last 6 months;
  • Indication for surgical treatment to be carried out within 6 months after the date of inclusion in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: AFO - Ankle_7 group
AFO is active comparator, ANKLE7 is the experimental treatment
Other: Ankle-7 - AFO group
AFO is active comparator, ANKLE7 is the experimental treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from right and left ankle joints power generation in stance phase after the use of first orthosis to right and left ankle joints power generation in stance phase after the use of second orthosis
Time Frame: After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
Measured by instrumental gait analysis (ratio of watt to kilogram)
After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
knee joint kinematics
Time Frame: After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
average extension in degrees of the right and left knees during initial contact, loading response and mid-stance measured by instrumental gait analysis
After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
stride length
Time Frame: After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
stride length right and left leg, measured by instrumental gait analysis (percentage of height)
After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
walking speed
Time Frame: After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
walking speed measured by instrumental gait analysis (ratio of percentage of height to seconds)
After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
preference of use of AFO or Ankle_7
Time Frame: After a 4-6 week period of use of first orthosis, after a 4-6 week period of use of second orthosis and after 3 months after three months when the child could freely use both orthoses
determined from a self- compiled diary
After a 4-6 week period of use of first orthosis, after a 4-6 week period of use of second orthosis and after 3 months after three months when the child could freely use both orthoses
clinical evaluation of the walking function
Time Frame: After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis
Using video-recording of children during walking and the Visual Gait Assessment Scale (OGS). (Boyd R, Graham HK. 1999)
After a 4-6 week period of use of first orthosis and after a 4-6 week period of use of second orthosis

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adriano Ferrari, University of Modena and Reggio Emilia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2012

Primary Completion (Actual)

May 15, 2017

Study Completion (Actual)

August 15, 2017

Study Registration Dates

First Submitted

October 2, 2017

First Submitted That Met QC Criteria

November 2, 2017

First Posted (Actual)

November 7, 2017

Study Record Updates

Last Update Posted (Actual)

November 7, 2017

Last Update Submitted That Met QC Criteria

November 2, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • UDGEE_2012_OTTObock

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

3
Subscribe